Evidence map›Paper›PMID 26637205›Full record

ArticleBMC bioinformatics2015

Rare variants analysis using penalization methods for whole genome sequence data.

Akram Yazdani, Azam Yazdani, Eric Boerwinkle

Abstract read
In one paragraph

Article in BMC bioinformatics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. [An improved association analysis pipeline for tumor susceptibility variant in haplotype amplification area].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Akram YazdaniHuman Genetics Center, University of Texas Health Science Center at Houston, TX, USA. akram.yazdani@uth.tmc.edu.
Azam YazdaniHuman Genetics Center, University of Texas Health Science Center at Houston, TX, USA. azam.yazdani@uth.tmc.edu.
Eric BoerwinkleHuman Genetics Center, University of Texas Health Science Center at Houston, TX, USA. Eric.Boerwinkle@uth.tmc.edu.

Funding

The Human Genome Sequencing CenterU54HG003273 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI GIBBS, RICHARD A · 2004 to 2015
$341.3M
Building on GWAS for NHLBI-disease: the CHARGE consortiumRC2HL102419 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2009 to 2010
$27.6M
NHGRI NIH HHS U54 HG003273NHLBI NIH HHS 5RC2HL102419NHLBI NIH HHS RC2 HL102419PHS HHS H H S N 268201100005CPHS HHS H H S N 2682011000 06CPHS HHS H H S N 268201100007CPHS HHS H H S N 268201100008CPHS HHS H H S N 268201100009CPHS HHS H H S N 268201100011CPHS HHS H H S N 268201100012CPHS HHS H H S N 68201100010C
6 · The paper itself

Abstract

backgroundAvailability of affordable and accessible whole genome sequencing for biomedical applications poses a number of statistical challenges and opportunities, particularly related to the analysis of rare variants and sparseness of the data. Although efforts have been devoted to address these challenges, the performance of statistical methods for rare variants analysis still needs further consideration.

resultWe introduce a new approach that applies restricted principal component analysis with convex penalization and then selects the best predictors of a phenotype by a concave penalized regression model, while estimating the impact of each genomic region on the phenotype. Using simulated data, we show that the proposed method maintains good power for association testing while keeping the false discovery rate low under a verity of genetic architectures. Illustrative data analyses reveal encouraging result of this method in comparison with other commonly applied methods for rare variants analysis.

conclusionBy taking into account linkage disequilibrium and sparseness of the data, the proposed method improves power and controls the false discovery rate compared to other commonly applied methods for rare variant analyses.

Indexed as

AlgorithmsGenetic Association StudiesGenome, HumanAtherosclerosisGenetic VariationHigh-Throughput Nucleotide SequencingHumansLinkage DisequilibriumPhenotypePrincipal Component Analysis

Identifiers

PMID26637205
PMCPMC4670502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.